These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21790895)

  • 1. Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Igawa T; Sato Y; Takata K; Fushimi S; Tamura M; Nakamura N; Maeda Y; Orita Y; Tanimoto M; Yoshino T
    Cancer Sci; 2011 Nov; 102(11):2103-7. PubMed ID: 21790895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.
    Sánchez-Beato M; Camacho FI; Martínez-Montero JC; Sáez AI; Villuendas R; Sánchez-Verde L; García JF; Piris MA
    Blood; 1999 Jul; 94(2):765-72. PubMed ID: 10397744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
    Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
    Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin D2 in chronic B-cell malignancies.
    Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
    Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
    Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
    Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
    [No Abstract]   [Full Text] [Related]  

  • 8. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
    Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
    Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
    Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
    Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.
    Decker T; Hipp S; Ringshausen I; Bogner C; Oelsner M; Schneller F; Peschel C
    Blood; 2003 Jan; 101(1):278-85. PubMed ID: 12393642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
    Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
    Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia.
    Teixeira Mendes LS; Peters N; Attygalle AD; Wotherspoon A
    J Clin Pathol; 2017 Oct; 70(10):899-902. PubMed ID: 28408436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Wu J; Zhang Y; Sun L; Zhai Q
    Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL.
    Halina A; Artur P; Barbara MK; Joanna S; Anna D
    Folia Histochem Cytobiol; 2010 Dec; 48(4):534-41. PubMed ID: 21478095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.